Demonstrates altered metastatic features in metastatic triple-negative breast cancer due to GPX4 inhibitor resistance, suggesting implications for therapy.
Key Points
The research aims to explore how GPX4 inhibitor resistance affects metastatic features in triple-negative breast cancer.
Cultured triple-negative breast cancer cell lines with GPX4 inhibitors